GRAND PHARMA(00512),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

00512 GRAND PHARMA

Not Yet Opened 12-18 16:08:14

7.980

+0.010

+0.13%

High8.130	Low7.910	Vol3.65M
Open8.120	D1 Closing7.970	Amplitude2.76%
Mkt Cap28.33B	Tradable Cap28.33B	Total Shares3.55B
T/O29.13M	T/O Rate0.10%	Tradable Shares3.55B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"00512","market":"HK","secType":"STK","nameCN":"GRAND PHARMA","latestPrice":7.98,"timestamp":1766045294002,"preClose":7.97,"halted":0,"volume":3646156,"delay":0,"floatShares":3549571148,"shares":3549571148,"eps":0.704885,"marketStatus":"Not Yet Opened","change":0.01,"latestTime":"12-18 16:08:14","open":8.12,"high":8.13,"low":7.91,"amount":29126937,"amplitude":0.027604,"askPrice":7.98,"askSize":2500,"bidPrice":7.95,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":0.594325,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766107800000},"marketStatusCode":0,"adr":0,"listingDate":819302400000,"exchange":"SEHK","adjPreClose":7.97,"dividendRate":0.032581,"openAndCloseTimeList":[[1766021400000,1766030400000],[1766034000000,1766044800000]],"volumeRatio":0.460103,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00512/wiki","defaultTab":"wiki","newsList":[{"id":"2592991654","title":"Grand Pharmaceutical Gets US FDA Nod for Trial of Tumor Diagnosis Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2592991654","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592991654?lang=en_us&edition=fundamental","pubTime":"2025-12-17 19:09","pubTimestamp":1765969772,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group (HKG:0512) obtained approval to conduct a phase I/II clinical study of GPN01530 from the United States Food and Drug Administration (FDA), a Wednesday Hong Kong bourse filing said.The trial will study the drug for the diagnosis of solid tumors.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"1195721045","title":"GRAND PHARMA (00512): Self-Developed Global Innovative Radiopharmaceutical GPN01530 Approved for Clinical Trials in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=1195721045","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195721045?lang=en_us&edition=fundamental","pubTime":"2025-12-17 18:10","pubTimestamp":1765966230,"startTime":"0","endTime":"0","summary":"GRAND PHARMA (00512) announced that its self-developed global innovative radiopharmaceutical conjugate (RDC) GPN01530 has recently received formal approval from the U.S. Food and Drug Administration...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","BK1161","BK1593","00512","BK1191","HK0000165453.HKD","BK1583"],"gpt_icon":0},{"id":"2592299687","title":"Grand Pharmaceutical Group Wins FDA Approval for Clinical Trials of Innovative Radionuclide-Drug Conjugate","url":"https://stock-news.laohu8.com/highlight/detail?id=2592299687","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592299687?lang=en_us&edition=fundamental","pubTime":"2025-12-17 18:01","pubTimestamp":1765965681,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group Ltd. has announced that its independently developed, globally innovative radionuclide-drug conjugate, GPN01530, has been approved by the United States Food and Drug Administration  to conduct a Phase I/II clinical trial for the diagnosis of solid tumors. This marks the company's first self-developed radionuclide-drug conjugate to receive FDA approval for clinical trials, representing a significant milestone in its global strategy for nuclear medicine anti-tumor diagnosis and treatment. There is no indication that the grant or regulatory approval was obtained by multiple organizations; the approval pertains solely to Grand Pharmaceutical Group Ltd.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grand Pharmaceu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL5lk3v8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2592599682","title":"BRIEF-Grand Pharmaceutical Says GPN01530 Approved For Clinical Trials In The United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2592599682","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592599682?lang=en_us&edition=fundamental","pubTime":"2025-12-17 18:00","pubTimestamp":1765965652,"startTime":"0","endTime":"0","summary":"BRIEF-Grand Pharmaceutical Says GPN01530 Approved For Clinical Trials In The United StatesDec 17  - Grand Pharmaceutical Group Ltd 0512.HK:GPN01530 APPROVED FOR CLINICAL TRIALS IN THE UNITED STATESFDA APPROVES GPN01530 FOR PHASE I/II CLINICAL STUDYFurther company coverage: 0512.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nFWN3XM0ZM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2592996838","title":"Grand Pharmaceutical Group Ltd - FDA Approves Gpn01530 for Phase I/Ii Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2592996838","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592996838?lang=en_us&edition=fundamental","pubTime":"2025-12-17 18:00","pubTimestamp":1765965625,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nFWN3XM0ZM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2592968849","title":"Grand Pharmaceutical Group Ltd - Gpn01530 Approved for Clinical Trials in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2592968849","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592968849?lang=en_us&edition=fundamental","pubTime":"2025-12-17 18:00","pubTimestamp":1765965625,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nFWN3XM0ZM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"1116198902","title":"Guoyuan International Maintains \"Buy\" Rating for GRAND PHARMA (00512) with Target Price of HK$11.88","url":"https://stock-news.laohu8.com/highlight/detail?id=1116198902","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116198902?lang=en_us&edition=fundamental","pubTime":"2025-12-15 17:30","pubTimestamp":1765791059,"startTime":"0","endTime":"0","summary":"Guoyuan International released a research report stating that GRAND PHARMA (00512) is experiencing sustained growth driven by the gradual launch of innovative products. The company's R&D progress in...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"1166683965","title":"Hong Kong Stock Movement | GRAND PHARMA (00512) Rises Over 3% Intraday as Traditional Chinese Medicine Innovation Drug GPN01360 Achieves Phase II Clinical Endpoint in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1166683965","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166683965?lang=en_us&edition=fundamental","pubTime":"2025-12-11 11:44","pubTimestamp":1765424656,"startTime":"0","endTime":"0","summary":"GRAND PHARMA (00512) surged over 3% intraday, with gains of 2.59% at the time of writing, trading at HK$8.32 and recording a turnover of HK$33.37 million. The company recently announced that its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","06978","BK1574","BK1161","159992","00512"],"gpt_icon":0},{"id":"1137125650","title":"GRAND PHARMA (00512): Traditional Chinese Medicine Class 1 Innovative Drug GPN01360 Successfully Reaches Clinical Endpoint in Phase II Study in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1137125650","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137125650?lang=en_us&edition=fundamental","pubTime":"2025-12-08 18:05","pubTimestamp":1765188325,"startTime":"0","endTime":"0","summary":"GRAND PHARMA (00512) announced that its innovative Traditional Chinese Medicine (TCM) drug GPN01360 for treating depression has successfully achieved the clinical endpoint in its Phase II study...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","00512","BK1500","BK1191","01360","BK1137","159992","BK1574","06978"],"gpt_icon":0},{"id":"2589393553","title":"Grand Pharmaceutical Group Reports Phase II Success for Innovative TCM Depression Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2589393553","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589393553?lang=en_us&edition=fundamental","pubTime":"2025-12-08 17:51","pubTimestamp":1765187512,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group Limited announced that its innovative traditional Chinese medicine, GPN01360, for the treatment of depression has successfully reached its clinical endpoint in a Phase II clinical trial conducted in China. The randomized, double-blind, placebo-controlled, multicenter study enrolled 148 patients who received oral administration of the drug over an eight-week period. The results mark a milestone for the company in the development of Chinese patent medicines within the ENT  segment. The company noted that the product remains in the R&D stage, and commercialization is subject to future regulatory approval. Details on the presentation of the study results were not specified in the announcement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL8DTpNR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2588007507","title":"Grand Pharmaceutical Group Issues Supplemental Disclosure on Directors’ and Senior Management Emoluments","url":"https://stock-news.laohu8.com/highlight/detail?id=2588007507","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588007507?lang=en_us&edition=fundamental","pubTime":"2025-12-04 17:17","pubTimestamp":1764839820,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group Ltd. has issued a supplemental announcement to its 2021 and 2022 annual reports, providing updated disclosure on directors' and senior management emoluments. The company clarified that no emoluments were paid as inducements to join or as compensation for loss of office during the relevant years, and updated the breakdown of emolument bands for directors and senior management. All other contents of the annual reports remain unchanged.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grand Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 04, 2025, and is solely responsible for t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nNDL2jw7Jv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2588008503","title":"Insiders hold 55% of Grand Pharmaceutical Group Limited (HKG:512), and they've been buying recently","url":"https://stock-news.laohu8.com/highlight/detail?id=2588008503","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588008503?lang=en_us&edition=fundamental","pubTime":"2025-12-04 06:18","pubTimestamp":1764800299,"startTime":"0","endTime":"0","summary":"Key Insights Grand Pharmaceutical Group's significant insider ownership suggests inherent interests in company's...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-512/grand-pharmaceutical-group-shares/news/insiders-hold-55-of-grand-pharmaceutical-group-limited-hkg51","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-512/grand-pharmaceutical-group-shares/news/insiders-hold-55-of-grand-pharmaceutical-group-limited-hkg51","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"1134728285","title":"10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=1134728285","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134728285?lang=en_us&edition=fundamental","pubTime":"2025-12-03 19:38","pubTimestamp":1764761917,"startTime":"0","endTime":"0","summary":"On December 3, 2025, the \"10th Zhitong Capital Market Annual Conference & Listed Companies Awards Ceremony,\" jointly hosted by leading Hong Kong and U.S. stock information platform Zhitong Finance...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1134","01093","LU0456827905.SGD","BK1579","LU1993786604.SGD","LU0531971595.HKD","LU0605514214.HKD","02100","BK1132","LU1166156734.SGD","BK1116","BK1167","02525","02158","01070","BK1619","LU2543165471.USD","BK1594","BK1617","BK1215","06821","BK1556","BK1183","IE00B031HY20.USD","LU0650527681.SGD","BK1169","BK1100","IE00BGHQDM52.EUR","80992","LU0561508036.HKD","LU0516423174.USD","LU1634259391.SGD","00017","SG9999002562.SGD","06609","BK1530","LU2238339852.HKD","LU1497734951.SGD","BK1235","IE0034224299.USD","SG9999015986.USD","03650","03896","LU2328871848.SGD","02018","BK1230","LU1211504680.USD","02419","LU0049112450.USD","01877","LU0505663152.USD","LU2097828631.EUR","LU1508157978.USD","BK1521","LU0327786744.USD","LU0082770016.USD","09959","BK1155","LU0456846285.SGD","BK1117","06657","01458","IE0008369823.USD","LU0251144936.SGD","BK1609","BK1512","LU1880383366.USD","BK1175","BK1194","BK1214","LU0307460666.USD","LU0502904849.HKD","BK1608","02190","09996","01939","LU0979878070.USD","09860","LU0516422366.SGD","SG9999002463.SGD","09923","LU0469268626.HKD","00460","LU1251922891.USD","01681","06963","LU2663582299.SGD","01773","LU1831875114.USD","LU1868837722.USD","IE00BPRC5H50.USD","01471","SG9999001093.SGD","SG9999004220.SGD","LU0164880469.USD","LU0823426308.USD","01833","SGXZ86797644.SGD","02150","LU0702159699.USD","02533","SG9999002828.SGD","BK1596","LU1226288170.HKD","LU0048597586.USD","00020","BK1198","HK0000252160.HKD","02256","LU0348735423.USD","LU2357125470.USD","02057","02197","LU0823397285.USD","01783","06608","LU0314109678.HKD","LU0737861772.HKD","01735","03681","LU0107464264.USD","LU1039395188.USD","02889","BK1575","LU2360107325.USD","00451","BK1207","00777","01651","06862","LU1226287792.SGD","LU1235295612.USD","02177","03738","IE00B543WZ88.USD","02331","06913","02469","BK1583","02279","80020","06613","BK1140","02020","LU1102505762.USD","LU0823414478.USD","LU0828237510.HKD","SG9999011746.SGD","BK1585","LU2242644610.SGD","BK1224","BK1193","BK1550","BK1564","LU0865486749.SGD","00798","LU0588545730.USD","01911","02595","LU1328277881.USD","BK1200","LU0823437842.USD","IE00BQXX3F31.USD","BK1539","02556","LU0880133367.SGD","02013","81211","BK1519","LU2778985437.USD","SG9999006514.SGD","02157","06160","01762","IE00BGV7N243.SGD","01384","LU0329678170.USD","BK1161","LU1226287875.USD","01519","LU0588545490.SGD","LU1267930227.SGD","LU1328615791.USD","01164","LU2460026573.USD","BK1109","LU0588545904.SGD","BK1197","BK1127","BYDDY","LU0791591158.USD","LU0594300179.USD","LU0261950983.USD","BK1209","SG9999001069.SGD","SG9999004311.SGD","LU0611395673.USD","BK1220","01907","00135","LU0828238088.HKD","00999","BK1233","BK1518","02250","02509","LU2097828805.USD","LU1152091754.HKD","LU1974910355.USD","LU1224709979.USD","02650","09877","LU0348767384.USD","09992","BK1126","00699","BK1598","LU0261947096.USD","03998","LU1951186391.HKD","LU0417516571.SGD","BK1615","02228","LU0173614495.USD","01809","BK1607","BK1229","09956","LU0348783233.USD","BK1160","02453","00302","LU0149721374.USD","LU0345775950.USD","LU0175139822.USD","LU2153592121.USD","LU0214875030.USD","LU2177674079.SGD","LU0011963245.USD","IE00BZ08YT58.USD","00003","LU2097828714.EUR","BK1147","LU0048575426.USD","00855","01880","IE0009570106.USD","02451","LU0072913022.USD","BK1566","IE00BMCWC346.EUR","BK1110","LU1917777945.USD","BK1502","BK1179","IE00BYV24P56.USD","LU1115378108.SGD","02627","00267","BK1136","02552","BK1610","LU1242518931.SGD","LU1023057109.AUD","LU0488056044.USD","BK1125","LU0128525689.USD","LU1861219969.SGD","06100","LU0164872284.USD","BK1221","BK1555","LU1102505929.USD","LU0431992006.USD","LU0708995583.HKD","BK1616","SG9999014674.SGD","LU2476274308.USD","LU0516422440.USD","LU2348774022.SGD","IE0031814852.USD","LU0531970944.HKD","LU1961090484.USD","BK1143","BK1595","BK1150","BK1128","LU1188198961.HKD","BK1593","LU0052756011.USD","BK1184","00656","LU2249611893.SGD","BK1186","02420","09690","BK1578","BK1228","LU0762540952.USD","BK1553","BK1151","HK0000165453.HKD","HK0000252152.HKD","LU0067412154.USD","LU2023250504.SGD","BK1227","BK1171","BK1523","ANPDY","BK1531","LU0251143458.SGD","BK1212","03677","LU0082770016.SGD","LU1497733631.SGD","IE00B5MMRT66.SGD","BK1216","BK1592","BK1516","LU0348805143.USD","02460","LU2039709279.SGD","03800","LU2106854487.HKD","LU2476274720.SGD","LU1880383440.USD","06168","LU0359201885.HKD","LU1046422090.SGD","BK1589","LU0051755006.USD","LU1808992512.USD","LU1770034418.SGD","LU0052750758.USD","BK1222","LU0588546209.SGD","LU0417516738.SGD","LU0359201612.USD","BK1604","LU0326950275.SGD","06058","BK1111","BK1549","BK1606","LU0540923850.HKD","SG9999015952.SGD","02315","00305","03396","01640","LU0640798160.USD","BK1548","BK1237","BK1590","BK1515","BK1178","IE00BZ08YR35.GBP","LU0348766576.USD","01952","00861","09660","LU2506951792.HKD","IE0003851619.USD","BK1219","03145","01585","LU0823414551.USD","02551","BK1574","BK1577","LU0819121731.USD","LU0541501648.USD","LU0868486357.SGD","BK1557","LU0264606111.USD","03680","02380","02171","BK1509","00867","LU1152091168.USD","BK1095","LU0048580855.USD","02629","LU0164939612.USD","LU0501845795.SGD","02567","BK1571","LU0211977185.USD","BK1148","00363","LU2399975544.HKD","02858","BK1164","SG9999006597.SGD","02121","06618","LU0620787316.HKD","06090","LU1981816686.USD","BK1158","BK1131","LU0572940350.SGD","00136","BK1239","02598","LU0572944931.SGD","BK1190","03709","BK1618","IE00BD6J9T35.USD","LU0072462343.USD","02268","LU0039217434.USD","LU0345776255.USD","IE00B8L5B284.USD","SG9999015945.SGD","01530","BK1504","LU0823426480.USD","BK1142","SGXZ90724238.SGD","01211","SG9999003461.SGD","BK1527","LU1969619763.USD","LU0593848301.USD","BK1541","LU0384037296.USD","LU0499858438.USD","02616","HK0000306701.USD","LU2097828557.USD","02511","LU0856984785.SGD","06677","09911","BK1189","00992","BK1524","02696","BK1154","BK1104","LU0791590937.USD","LU0310800965.SGD","IE00BVYPNP33.GBP","LU1303224171.USD","LU0455707207.USD","LU0231483743.USD","HK0000320264.USD","LU0594300419.USD","LU1282649067.USD","01276","BK1522","BK1586","LU2097828474.EUR","00884","BK1114","LU0634319403.HKD","BK1528","LU1720050803.USD","00384","09919","LU2506952253.HKD","LU0449515922.USD","LU0228659784.USD","01739","LU0348825331.USD","BK1195","LU0289739343.SGD","LU1226288253.USD","LU0261950470.USD","06069","BK1544","BK1613","09890","00826","LU0043850808.USD","LU2008162690.USD","LU0140636845.USD","LU0819123356.HKD","01117","LU2294711713.HKD","02392","LU1939255532.USD","LU0315179316.USD","09990","IE00B031J352.USD","LU1522347837.USD","SG9999015978.USD","IE0032431581.USD","LU0737861699.HKD","IE00B0169L03.USD","00666","LU0516422952.EUR","01520","LU1861214812.USD","LU0084288322.USD","06138","BK1587","LU1794554557.SGD","LU0348827113.USD","LU0543330566.HKD","IE00BZ08YS42.EUR","02436","IE0008368742.USD","BK1188","09985","00512","LU1366334651.USD","09961","09955","82331","LU0871576103.HKD","01440","86618","03836","02273","02298","LU0143863784.USD","09636","LU0254981946.USD","LU0269904917.USD","BK1605","LU0143863198.USD","LU1813983027.USD","LU0823397103.USD","02670","01177","LU2153591404.USD","BK1588","02498","02142","SG9999000459.SGD","02276","BK1144","BK1520","LU0359202008.SGD","09926","02886","BK1137","BK1119","06988","BK1600","LU0831093199.SGD","LU2298064838.USD","LU0417516902.SGD","02155","LU1807302812.USD","HK0000306685.HKD","LU0463099449.HKD","LU0054237671.USD","06186","IE00B8HQ1Z84.USD","LU1481107354.HKD","BK1540","LU0054450605.USD","09878","LU3063872942.SGD","BK1168","09880","02096","09927","BK1253","SG9999000418.SGD","06919","BK1554","09639","01119","HK0000500386.USD","02565","02145","BK1139","IE00B0JY6N72.USD","LU0348784397.USD","01448","01818","LU0244354667.USD","01378","02488","LU2449936058.SGD","IE0003795394.USD","LU1719994722.HKD","LU0449509016.USD","SG9999000475.SGD","03939","02431","LU0289960550.SGD","HYDD.SI","01318","002594","LNNGY","BK1542","LU2348773727.SGD","LU0511384066.AUD","BK1582","06633","BK1191","LU0509642566.USD","BK1247","00300","BK1163","BK1591","BK1258","02590","LU0320764599.SGD","LU1008478684.HKD","LU2045819591.USD","BK1124","LU0274383008.USD","02400","LU1956131251.USD","02167","LU1366334578.USD","00875","LU2424517915.HKD","LU1868838027.USD","LU2488822045.USD","02506","09678","LU0164865239.USD","00382","LNVGY","LU0229945570.USD","LU0259732245.USD","LU0315178854.USD","LU1226287529.USD","BK1552","LU0823038988.USD","BK1240","LU0370786039.SGD","LU1868837565.USD","09699","02587","LU1242518857.USD","01333","IE00B29SXG58.USD","LU0823039010.USD","LU0572939691.SGD","BK1170","01969","LU1048588211.SGD","LU0499858602.USD","82020","01405","06683","LU0289961442.SGD","LU1497733557.USD","IE00BVYPNQ40.USD","LU0541502299.USD","SG9999001903.USD","SG9999001051.SGD","03658","LU2125910500.SGD","01600","BK1559","LU0287142896.SGD","BK1526","IE00BQXX3C00.GBP","BK1560","06086","LU1960683339.HKD","LU1675838814.USD","LU1282649810.SGD","02382","LU1634259557.SGD","02411","HK0000320223.HKD","LU0329678337.USD","LU0516423091.SGD","SG9999001226.SGD","LU0165289439.USD","06060","BK1096","06855","BK1597","BK1225","LU1770036033.HKD","IE00BQXX3D17.EUR","SG9999002950.SGD","06996","BK1141","SGXZ62798434.SGD","BK1500","00960","BK1257","02105"],"gpt_icon":1},{"id":"1125240666","title":"Chairman Tang Weikun Increases Stake in GRAND PHARMA (00512) with 50,000 Shares at HK$8.28 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1125240666","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125240666?lang=en_us&edition=fundamental","pubTime":"2025-11-21 19:06","pubTimestamp":1763723197,"startTime":"0","endTime":"0","summary":"Hong Kong Stock Exchange filings reveal that on November 18, Chairman Tang Weikun purchased an additional 50,000 shares of GRAND PHARMA (00512) at HK$8.28 per share, totaling HK$414,000. Following...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"1162136231","title":"GRAND PHARMA (00512) Shareholder Equity Disclosure on November 19","url":"https://stock-news.laohu8.com/highlight/detail?id=1162136231","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162136231?lang=en_us&edition=fundamental","pubTime":"2025-11-19 08:06","pubTimestamp":1763510777,"startTime":"0","endTime":"0","summary":"It was noted that GRAND PHARMA (00512) disclosed its latest shareholder equity changes on November 19, 2025. Stock Name: GRAND PHARMA (00512)   Institution/Individual: Tang Weikun   Position Type:...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"1197192959","title":"GRAND PHARMA's Innovative Allergic Rhinitis Combination Nasal Spray Approved for Launch in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1197192959","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197192959?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:50","pubTimestamp":1762951833,"startTime":"0","endTime":"0","summary":"Recently, GRAND PHARMA announced that its jointly developed compound nasal spray of olopatadine hydrochloride and mometasone furoate (brand name: Ryaltris) has been approved by China's National...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2582346936","title":"Is Weakness In Grand Pharmaceutical Group Limited (HKG:512) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?","url":"https://stock-news.laohu8.com/highlight/detail?id=2582346936","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582346936?lang=en_us&edition=fundamental","pubTime":"2025-11-12 11:39","pubTimestamp":1762918784,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group (HKG:512) has had a rough week with its share price down 3.1%. However, a closer look at its...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-512/grand-pharmaceutical-group-shares/news/is-weakness-in-grand-pharmaceutical-group-limited-hkg512-sto-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-512/grand-pharmaceutical-group-shares/news/is-weakness-in-grand-pharmaceutical-group-limited-hkg512-sto-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"1192723848","title":"Financial Highlights: China's Ministry of Finance Becomes Controlling Shareholder of Bank of Communications (03328), Beike-W (02423) Q3 Net Profit Drops 36.1% YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=1192723848","media":"Stock News","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192723848?lang=en_us&edition=fundamental","pubTime":"2025-11-11 07:30","pubTimestamp":1762817453,"startTime":"0","endTime":"0","summary":"【Top News】   Bank of Communications (03328): Ministry of Finance Becomes Controlling Shareholder   Bank of Communications announced that Guotai Haitong Securities issued a continuous supervision...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1097","BK0020","LU0244354667.USD","LU1688375341.USD","00603","LU0651947912.USD","LU0287142896.SGD","LU1051769294.HKD","LU2778985437.USD","BEKE","LU0359201612.USD","SG9999001226.SGD","BK0278","BK1231","LU0359202008.SGD","03328","BK4526","SG9999001093.SGD","BK0015","BK1191","LU1051768304.USD","LU1831875114.USD","BK0183","BK1119","LU0463099449.HKD","LU0326950275.SGD","LU0173614495.USD","LU1188198961.HKD","02238","LU0651946864.USD","LU0359201885.HKD","LU2476274308.USD","BK0028","BK4548","BK4585","BK4509","BK0187","BK4505","BK1566","601328","BK1221","BK0012","01921","BK4079","BK0188","BK1539","00512","BK1202","BK4588","BK1560","BK4504","LU1515016050.SGD","02423","LU1023057109.AUD"],"gpt_icon":0},{"id":"2582182251","title":"BRIEF-Grand Pharmaceutical Says Ryaltris Compound Nasal Spray Granted Drug Registration Certificate By NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2582182251","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582182251?lang=en_us&edition=fundamental","pubTime":"2025-11-10 18:22","pubTimestamp":1762770139,"startTime":"0","endTime":"0","summary":"BRIEF-Grand Pharmaceutical Says Ryaltris Compound Nasal Spray Granted Drug Registration Certificate By NMPANov 10  - Grand Pharmaceutical Group Ltd 0512.HK:RYALTRIS COMPOUND NASAL SPRAY DEVELOPED BY GLENMARK SPECIALTY S.A. GRANTED DRUG REGISTRATION CERTIFICATE BY NMPAFurther company coverage: 0512.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nFWN3WK029:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"1185818533","title":"GRAND PHARMA (00512): Global Innovative Product Ryaltris® Nasal Spray Approved for Launch in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1185818533","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185818533?lang=en_us&edition=fundamental","pubTime":"2025-11-10 17:54","pubTimestamp":1762768471,"startTime":"0","endTime":"0","summary":"GRAND PHARMA (00512) announced that Ryaltris® (GSP 301 NS), a globally innovative compound nasal spray developed by Glenmark Specialty S.A. (Glenmark), has recently received drug registration...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinagrandpharm.com","stockEarnings":[{"period":"1week","weight":-0.0268},{"period":"1month","weight":-0.0351},{"period":"3month","weight":-0.0817},{"period":"6month","weight":-0.0545},{"period":"1year","weight":0.7389},{"period":"ytd","weight":0.7389}],"compareEarnings":[{"period":"1week","weight":-0.0013},{"period":"1month","weight":-0.0167},{"period":"3month","weight":-0.0394},{"period":"6month","weight":0.0836},{"period":"1year","weight":0.2836},{"period":"ytd","weight":0.2711}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"China Grand Pharmaceutical and Healthcare Holdings Ltd is a Hong Kong-based investment holding company principally engaged in the manufacturing and sales of pharmaceutical preparations and medical devices. The Company is principally engaged in manufacturing and sales of pharmaceutical preparations and medical devices, bio-technology products, nutrition products, specialised pharmaceutical raw materials and other products. The main products of the Company cover the anti-tumor, cardiovascular emergency pharmaceutical products and advanced cerebro-cardiovascular intervention advanced medical devices, anti-virus and anti-infection, respiratory and ear-nose-throat (ENT), bio-health products and specialized pharmaceutical ingredients.","yearOnYearQuotes":[{"month":1,"riseRate":0.466667,"avgChangeRate":0.087032},{"month":2,"riseRate":0.7,"avgChangeRate":0.108479},{"month":3,"riseRate":0.4,"avgChangeRate":0.019078},{"month":4,"riseRate":0.633333,"avgChangeRate":0.018767},{"month":5,"riseRate":0.466667,"avgChangeRate":0.084333},{"month":6,"riseRate":0.366667,"avgChangeRate":-0.048262},{"month":7,"riseRate":0.366667,"avgChangeRate":-0.015905},{"month":8,"riseRate":0.4,"avgChangeRate":0.007133},{"month":9,"riseRate":0.466667,"avgChangeRate":-0.039275},{"month":10,"riseRate":0.5,"avgChangeRate":-0.014834},{"month":11,"riseRate":0.5,"avgChangeRate":0.085694},{"month":12,"riseRate":0.5,"avgChangeRate":-0.007069}],"exchange":"SEHK","name":"GRAND PHARMA","nameEN":"GRAND PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GRAND PHARMA(00512),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GRAND PHARMA(00512) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GRAND PHARMA,00512,GRAND PHARMA股票,GRAND PHARMA股票老虎,GRAND PHARMA股票老虎国际,GRAND PHARMA行情,GRAND PHARMA股票行情,GRAND PHARMA股价,GRAND PHARMA股市,GRAND PHARMA股票价格,GRAND PHARMA股票交易,GRAND PHARMA股票购买,GRAND PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GRAND PHARMA(00512),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GRAND PHARMA(00512) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}